InvestorsHub Logo
Followers 3
Posts 389
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Thursday, 01/19/2017 6:45:10 AM

Thursday, January 19, 2017 6:45:10 AM

Post# of 3552
Pulmatrix Inc. (PULM) announced Tuesday morning that the FDA has designated PUR1900, its drug candidate for treating fungal infections in the lungs of CF patients, as a "Qualified Infectious Disease Product."

Pulmatrix climbed for the bulk of the morning Tuesday and finished with a gain of 0.87 at $1.55 on the highest volume of the year. The stock surged to over a 2 1/2 month high.

http://www.rttnews.com/2733864/pulmatrix-inc-pulm-leaped-to-over-a-2-month-high-on-fda-news.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PULM News